These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3412139)

  • 41. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nuclear magnetic resonance of plasma? A method for the diagnostic and therapeutic control of cancer?].
    Sezer O; Rasche H; Stelten J; Leibfritz D
    Dtsch Med Wochenschr; 1988 Apr; 113(17):705-6. PubMed ID: 3359939
    [No Abstract]   [Full Text] [Related]  

  • 44. Can NMR of a blood sample detect cancer or not?
    Oncology (Williston Park); 1990 Oct; 4(10):12, 15. PubMed ID: 2149822
    [No Abstract]   [Full Text] [Related]  

  • 45. [A method of NMR-relaxometry of the blood serum applicable to the diagnosis of malignant neoplasms].
    Papish EA; Kariakina NF
    Vestn Akad Med Nauk SSSR; 1989; (7):74-81. PubMed ID: 2683466
    [No Abstract]   [Full Text] [Related]  

  • 46. [Nuclear magnetic resonance relaxation of the blood in patients with burns].
    Kozinets GI; Popova OV; Ignatov SV; Gangardt MG
    Lab Delo; 1991; (3):13-6. PubMed ID: 1710708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood serum concentration and urinary excretion of myoinositol in patients with malignant tumors].
    Trznadel K; Walasek L; Lutz W; Nagański T; Fajndt S
    Pol Tyg Lek; 1977 Nov; 32(46):1785-7. PubMed ID: 593947
    [No Abstract]   [Full Text] [Related]  

  • 48. [Elevation of "pregnancy-associated alpha 2 glycoprotein" in patients with malignant tumors. Analysis of cases].
    Munzarová M; Kubícek R; Trnka A; Hrozová L; Cerbáková B
    Vnitr Lek; 1978 Dec; 24(12):1158-63. PubMed ID: 726326
    [No Abstract]   [Full Text] [Related]  

  • 49. NMR--another cancer-test disappointment.
    Shulman R
    N Engl J Med; 1990 Apr; 322(14):1002-3. PubMed ID: 2314436
    [No Abstract]   [Full Text] [Related]  

  • 50. Proton NMR relaxation times in the peripheral blood of cancer patients.
    Ekstrand KE; Dixon RL; Raben M; Ferree CR
    Phys Med Biol; 1977 Sep; 22(5):925-31. PubMed ID: 561969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer-induced decreases in human plasma proton NMR relaxation rates.
    McLachlan LA
    Phys Med Biol; 1980 Mar; 25(2):309-15. PubMed ID: 7384216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An NMR blood test for cancer: a critical assessment.
    Fossel ET
    NMR Biomed; 1989 Jul; 2(2):87. PubMed ID: 2641296
    [No Abstract]   [Full Text] [Related]  

  • 53. NMR characterisation of healthy rat tissues in vivo.
    Taylor DG; Bushell MC
    Clin Phys Physiol Meas; 1986 Feb; 7(1):57-62. PubMed ID: 3956119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolongation of T1 relaxation time in NMR examinations--attempt at its interpretation].
    Sieroń A; Zmudziński J; Adamek M
    Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):373-5. PubMed ID: 2626356
    [No Abstract]   [Full Text] [Related]  

  • 55. NMR spectroscopy and cancer research: the present and the future.
    Smith IC; Chmurny GN
    Anal Chem; 1990 Aug; 62(15):853A-859A. PubMed ID: 2205124
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the changes of the metabolites added to the serum of the malignant tumor patients].
    YAMAGUCHI H; KURAHORI T; NAKANO S; UKITA H; SAEGUSA T; UETSUKI S
    Gan; 1956 Dec; 47(3-4):265-7. PubMed ID: 13414995
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum DNA levels in patients with malignant disease.
    Perlin E; Moquin RB
    Am J Clin Pathol; 1972 Nov; 58(5):601-2. PubMed ID: 4642166
    [No Abstract]   [Full Text] [Related]  

  • 58. [Certain physicochemical properties of blood serum in malignant tumors].
    STRYCEK R; SABLIK J
    Cas Lek Cesk; 1951 Oct; 90(41):1216-20. PubMed ID: 14879430
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of standardized indices in the study on spreading of malignant tumors].
    MERKOV AM
    Vopr Onkol; 1961; 7(6)():3-8. PubMed ID: 13769646
    [No Abstract]   [Full Text] [Related]  

  • 60. [NMR-relaxation of blood serum in cancer patients].
    Papish EA; Temkina TIa; Kariakina NF
    Med Radiol (Mosk); 1988 Aug; 33(8):47-50. PubMed ID: 3412139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.